jRCT2031230352
Untitled Trial
A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL 23 Pathway to Establish Efficacy in Pediatric Crohn's Disease (MACARONI 23)
Janssen Pharmaceutical K.K.·Japan Registry Clinical TrialNot yet recruiting
Study focus
- Disease/Condition
- Crohn's Disease
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Janssen Pharmaceutical K.K.
- Location
- Australia;Belgium;Brazil;Canada;Switzerland;Czech;Spain;France;United Kingdom of Great Britain;Israe
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease [regional enteritis]Crohn disease of small intestine
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2031230352
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2031230352 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen Pharmaceutical K.K. and is currently Not yet recruiting. The study focuses on Crohn's Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.